by John Warren | Jan 20, 2025
The 2025 National Comprehensive Cancer Network® (NCCN®) Guidelines for Patients provide a comprehensive roadmap for genetic testing aimed at hereditary cancers, including breast, ovarian, pancreatic, and prostate cancers. This resource emphasizes the critical role of...
by John Warren | Oct 11, 2024
Becker’s Payer Issues recently interviewed 16 healthcare executives about issues that are presenting challenges to the payer community. In today’s evolving healthcare landscape, it’s not just insurance payers feeling the strain of regulatory and political...
by John Warren | Apr 16, 2024
In their FY 2025 Inpatient Prospective Payment System proposed rule, CMS proposes a policy that would increase Medicare payment for gene therapy targeting sickle cell disease. CMS asserts that these additional New Technology Add-on Payments would increase access to...
by John Warren | Apr 15, 2024
As a part of the CMS FY 2025 Inpatient Prospective Payment System proposed rule, CMS followed up on its promise from last year to propose policies that would help the hospital industry to maintain access to essential medicines. But could this Medicare Essential...
